Key result
IL-1α, IL-6, butyrate, and dexamethasone increase secreted SAA ~4-fold in HUH-7 cells.
Why the study?
Concentrations of liver-secreted serum amyloid A and apolipoprotein A-I are inversely related under normal and acute-phase conditions, motivating an evaluation of how cytokines, butyrate, and dexamethasone affect their synthesis in human HUH-7 hepatoma cells.
Answers are grounded in this paper and cite their sources.
In vitro hepatoma data on SAA and apo A-I regulation leave open clinical translation to inflammation or cardiovascular risk; human studies needed.
Serum amyloid A (SAA) and apolipoprotein A-I (apo A-I) are secreted by the liver. As concentrations of both apolipoproteins are inversely related under normal and acute-phase conditions, human HUH-7 hepatoma cells were stimulated with interleukin (IL)-1alpha (100 and 200 U), IL-6 (50 and 100 U), butyrate (2 mM) and dexamethasone (2 x 10(-7)M and 1 x 10(-6)M), alone or in combination. Changes in SAA and apo A-I synthesis were monitored after metabolic labelling of the cells with [35S]-methionine. Intracellular and secreted SAA and apo A-I were immunoprecipitated, separated by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), and the radioactivity in the corresponding bands was counted. Intracellular apolipoprotein levels were increased by all stimuli, either alone or in combination, between 2.7- and 5.5-fold (SAA) and between 2.8- and 4.1-fold (apo A-I), respectively. In a similar manner, apolipoprotein levels secreted by HUH-7 cells were increased between 3.1- and 4.3-fold (SAA) and between 1.9- and 3. 3-fold (apo A-I). Co-administration of cytokines, butyrate and/or dexamethasone had no pronounced synergistic effect on intracellular biosynthesis and secretion of SAA and apo A-I. The results from the present study suggest that apo A-I must not necessarily be considered as a negative acute-phase reactant.
No takes yet. Share an insight, caveat, or question.
Malle et al. (1999) studied Acute-phase response (in vitro human HUH-7 hepatoma cells). Interleukin-1alpha, Interleukin-6, butyrate, and dexamethasone (alone or in combination) vs. Unstimulated control cells was evaluated on Intracellular biosynthesis and secretion of serum amyloid A (SAA) and apolipoprotein A-I (apo A-I) (Intracellular: 2.7- to 5.5-fold (SAA) and 2.8- to 4.1-fold (apo A-I); Secreted: 3.1- to 4.3-fold (SAA) and 1.9- to 3.3-fold (apo A-I)). Stimulation with IL-1alpha, IL-6, butyrate, and dexamethasone increased secreted SAA by 3.1- to 4.3-fold and apo A-I by 1.9- to 3.3-fold in HUH-7 cells.
Synapse has enriched 10 related papers. Consider them for comparative context: